Abstract:Objective To investigate the expression of eukaryotic translation initiation factor 4 gamma 1(EIF4G1) in non-small cell lung cancer(NSCLC) and its clinical significance. Methods The cancer tissues and paired adjacent normal lung tissues of 81 patients with NSCLC were collected. The mRNA and protein expression of EIF4G1 was detected by qRT-PCR and immunohistochemistry, respectively. The relationship between EIF4G1 expression and the clinicopathological features of NSCLC was analyzed. Results The ΔCt value of EIF4G1 mRNA in the cancer tissues was significantly lower than that in the matched adjacent tissues(6.92±1.87 vs. 8.33±1.69, t=7.013, P<0.001). There were significant differences in EIF4G1 expression among different types of NSCLC(P<0.05). The expression level of EIF4G1 mRNA in poorly differentiated cancer tissues(8.90±1.33) was significantly higher than that in moderately differentiated(1.70±0.17) and highly differentiated(0.84±0.15) cancer tissues(F=14.04, P<0.001). The expression level of EIF4G1 mRNA in cancer tissues from the patients with clinical stage of Ⅳ(15.42±3.99) was significantly higher than that in stages I, II and III(1.67±0.37, 2.96±0.77 and 5.44±0.99, F=11.84, P<0.001). There was no significant difference in the expression level of EIF4G1 mRNA between subjects with different age, sex and pathological types(P>0.05). Logistic regression analysis showed that high EIF4G1 expression was closely correlated with cell differentiation(OR=23.74, P<0.001). The immunohistochemical results showed that the protein expression level of EIF4G1 in the low differentiated carcinoma tissues was significantly higher than that in the moderately and highly differentiated carcinoma tissues(P<0.05). Conclusion EIF4G1 is highly expressed in NSCLC, and its expression level is closely related to the cell differentiation of NSCLC.